In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial found.
Budesonide (micronized ... the 3 clinical trials showed that treatment with Pulmicort Respules doses of 0.25 mg once daily, 0.25 mg twice daily, and 0.5 mg twice daily achieved statistically ...
Budesonide (micronized ... a target fill weight of 165 mg (range 140-190). Pulmicort Flexhaler should be stored in a dry place at controlled room temperature 20-25°C (68-77°F) with the cover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results